The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Scot Garg

Showing 1-20 of 26 articles
Coronary interventions
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Coronary interventions
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F
December 20, 2019 | 10.4244/EIJ-D-19-00202
Coronary interventions
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber C, Sabaté M, Iqbal J, Wykrzykowska J, Piek J, Spitzer E, Jüni P, Hamm C, Steg P, Valgimigli M, Vranckx P, Windecker S, Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Coronary interventions
Interventional cardiology: review of the year 2017
Modolo R, Miyazaki Y, Chichareon P, Asano T, Collet C, Tenekecioglu E, Katagiri Y, Soliman O, Garg S, Onuma Y, Serruys P
April 20, 2018 | 10.4244/EIJ-D-18-00066
Coronary interventions
How should I treat a patient with giant left main coronary artery aneurysm without associated stenosis?
Ormerod J, Lim J, Chandrasekaran B, Ramcharitar S, Garg S, Singh R, McDonald J, Balachandran K, Wykrzykowska J
January 20, 2016 | 10.4244/EIJV11I9A217
The FIREHAWK® stent: will it achieve its potential?
Garg S
May 21, 2013 | 10.4244/EIJV9I1A2
Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe
Vranckx P, Boersma E, Garg S, Valgimigli M, Van Es G-A, Goedhart D, Serruys P
November 30, 2011 | 10.4244/EIJV7I7A134
Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial
Wykrzykowska J, Garg S, Onuma Y, de Vries T, Morel M, Van Es G-A, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice M, Di Mario C, van Geuns R, Jüni P, Windecker S, Serruys P
September 30, 2011 | 10.4244/EIJV7I5A97
How should I treat impaired systolic function and clinical deterioration after surgery of type A aortic dissection?
Gutiérrez-Chico J-L, Garcia-Garcia H, Ligthart J, Bol-Raap G, Garg S, Bekkers J, Serruys P
September 30, 2011 | 10.4244/EIJV7I5A102
Moxy® drug-coated balloon: a novel device for the treatment of coronary and peripheral vascular disease
Gutiérrez-Chico J-L, Regar E, van Geuns R, Garg S, Schultz C, Van Mieghem N, Duckers H, Serruys P
June 30, 2011 | 10.4244/EIJV7I2A44
Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study
Garg S, Sarno G, Gutiérrez-Chico J-L, Garcia-Garcia H, Gomez-Lara J, Serruys P
April 20, 2011
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study
Brugaletta S, Garcia-Garcia H, Diletti R, Gomez-Lara J, Garg S, Onuma Y, Shin E, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Dorange C, Veldhof S, Rapoza R, Sudhir K, Bruining N, Ormiston J, Serruys P
April 20, 2011
The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer
Garg S, Wykrzykowska J, Serruys P, de Vries T, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, Tyczynski P, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S
March 21, 2011
Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study
Sarno G, Garg S, Gomez-Lara J, Garcia-Garcia H, Ligthart J, Bruining N, Onuma Y, Witberg K, van Geuns R, de Boer S, Wykrzykowska J, Schultz C, Duckers H, Regar E, de Jaegere P, de Feyter P, Van Es G-A, Boersma E, van der Giessen WJ, Serruys P
March 21, 2011
Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)
Legrand V, Garg S, Serruys P, Virtanen K, Szurawitzki G, Voudris V, Fontanelli A, Endersen K, Kranjec I, Rademaker T, Stefanadis C, Wittebols K
February 21, 2011
A comparison of the distribution of necrotic core in bifurcation and non-bifurcation coronary lesions: an in vivo assessment using intravascular ultrasound radiofrequency data analysis
Garcia-Garcia H, Gomez-Lara J, Gonzalo N, Garg S, Shin E, Goedhart D, Serruys P
August 15, 2010
The coronary Stent-On-A-Wire (SOAW)
Sarno G, Okamura T, Gomez-Lara J, Garg S, Girasis C, Kopia G, Pomeranz M, Easterbrook W, van Geuns R, van der Giessen WJ, Serruys P
August 15, 2010
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study
Serruys P, Garg S, Abizaid A, Ormiston J, Windecker S, Verheye S, Dubois C, Stewart J, Hauptmann K, Schofer J, Stangl K, Witzenbichler B, Wiemer M, Barbato E, de Vries T, Drijver A-M, Otake H, Meredith L, Toyloy S, Fitzgerald P
June 30, 2010
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer
Garg S, Sarno G, Serruys P, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S
June 30, 2010
How should I treat a tortuous calcified right coronary artery?
Garg S, Schultz C, Sarno G, Serruys P
May 25, 2010

Latest news

NEW ISSUE
State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more
October 20, 2021
STATE OF THE ART
Valve-in-valve TAVI: a practical overview
Giuseppe Tarantini et al.
October 20, 2021
AHEAD OF PRINT
TAVI in younger (<70 years old) patients: the AMTRAC registry
Guy Witberg et al.
October 22, 2021
AHEAD OF PRINT
Impact of LVOT calcification in transfemoral TAVI patients
L. Waldschmidt et al.
October 19, 2021
VIEWPOINT
My Stroke Story
Marco Noc
October 20, 2021
AHEAD OF PRINT
Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial
Hironori Hara et al.
October 22, 2021
AHEAD OF PRINT
Serum caffeine causes adenosine-induced FFR overestimation
Hideaki Tanaka et al.
October 15, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke